Upper limb venous thrombosis complicating amyloidosis

Irish Journal of Medical Science (Impact Factor: 0.83). 01/1987; 155(12):437-8. DOI: 10.1007/BF02940549
Source: PubMed


Summary A case of upper limb venous thrombosis in a patient with nephrotic syndrome secondary to amyloidosis is described. Although
thrombosis of both venous and arterial systems is a recognised complication of the nephrotic syndrome, the site reported is
rare. There is no evidence that amyloidosis in the absence of nephrotic syndrome is associated with an increased clotting
tendency; haemorrhage appears more likely.

0 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: To study, by literature review, the management of subclavian-axillary vein thrombosis (SAVT) and to make recommendations. The MEDLINE database and cross-referenced articles. Key words subclavian-axillary vein thrombosis, venous thrombosis, Paget-Schroetter syndrome, anticoagulation, and thrombolysis were used to extract articles related to SAVT. Independent extraction of articles by 2 observers. Although numerous studies are available in the literature, they vary widely in their patient selection, treatment methods, follow-up and conclusions. As such, the management of patients with SAVT remains controversial. Anticoagulation remains the initial treatment of choice for acute SAVT although there is definitely a role for thrombolysis and surgery in selected cases. Surgical intervention should be reserved for patients in whom there is a specific indication. Since chronic symptoms depend largely on the etiology of the disease, treatment should be tailored to address the causative factors. A multicentre, prospective study is necessary to evaluate the optimum management strategies for patients with SAVT.
    No preview · Article · Mar 1998 · Canadian journal of surgery. Journal canadien de chirurgie
  • [Show abstract] [Hide abstract]
    ABSTRACT: Nephrotic syndrome increases the tendency to thromboembolic complications in both adults and children. Changes in the plasma concentrations of many proteins concerned with regulation of clotting and fibrinolytic systems, hyperviscosity, dehydration, corticosteroid and diuretic therapy may also contribute to thromboembolism. In addition, some of the genetic disorders also increase tendency to thromboembolic events. One of these disorders is methylene tetrahydrofolate reductase (MTHFR) A1298C mutation, which may cause hyperhomocysteinemia and thrombotic events when the folate level is low. A 26-year-old female was admitted to hospital with upper extremity deep vein thrombosis and nephrotic range proteinuria. On her renal biopsy, membranoproliferative glomerulonephritis (MPGN) was found. The other causes of thrombosis were excluded and homozygosity for the MTHFR A1298C mutation was determined. The levels of homocysteine and folic acid were normal. We report a first case of MPGN together with homozygosity for MTHFR 1298C mutation in adult nephrotic syndrome, complicated with unusual upper extremity venous thrombosis.
    No preview · Article · May 2014 · Turkish Nephrology